Teradyne (TER) Research & Development (2009 - 2026)

Teradyne (TER) has reported Research & Development for 18 consecutive years, with $156.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development rose 32.02% year-over-year to $156.3 million; the trailing twelve-month figure through Jun 2026 stood at $559.9 million (up 16.05% YoY), and the FY2025 full-year result was $504.6 million, up 9.49% from the prior year.
• Research & Development rose to $156.3 million in Q2 2026 per TER's latest filing, from $135.6 million in the prior quarter.
• Across five years, Research & Development topped out at $156.3 million in Q2 2026 and bottomed at $102.2 million in Q4 2023.
• Historically, Research & Development has averaged $117.6 million across 5 years, with a median of $111.9 million in 2022.
• The sharpest annual moves came in 2023 and 2026: Research & Development slipped 6.54% in 2023, then jumped 32.02% in 2026.
• Over 5 years, Research & Development stood at $108.8 million in 2022, then dropped by 6.07% to $102.2 million in 2023, then advanced by 25.61% to $128.4 million in 2024, then rose by 11.59% to $143.3 million in 2025, then gained by 9.09% to $156.3 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $156.3 million, $135.6 million, and $143.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.